Determination of polyoxyethyleneglycerol triricinoleate 35 (Cremophor EL) in plasma by pre-column derivatization and reversed-phase high-performance liquid chromatography
- 7 June 1996
- journal article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 681 (2) , 355-362
- https://doi.org/10.1016/0378-4347(95)00544-7
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Tissue distribution, metabolism and excretion of paclitaxel in miceAnti-Cancer Drugs, 1996
- The alteration of plasma lipoproteins by cremophor ELJournal of Photochemistry and Photobiology B: Biology, 1994
- Synergistic reversal of multidrug-resistance phenotype in acute myeloid leukemia cells by cyclosporin A and cremophor ELBlood, 1994
- Measurement of Cremophor EL Following Taxol: Plasma Levels Sufficient to Reverse Drug Exclusion Mediated by the Multidrug-Resistant PhenotypeJNCI Journal of the National Cancer Institute, 1993
- The polyoxyethylene castor oil Cremophor EL modifies multidrug resistanceBritish Journal of Cancer, 1990
- High-performance liquid chromatographic determination of free fatty acids with 1-naphthylamineJournal of Chromatography B: Biomedical Sciences and Applications, 1983
- Gas-liquid partition chromatography: the separation and micro-estimation of volatile fatty acids from formic acid to dodecanoic acidBiochemical Journal, 1952